Partnering Opportunities
DBV is currently seeking partnership opportunities around its allergy desensitisation and epicutaneous vaccination programmes. The company’s epicutaneous vaccine administration programme has demonstrated positive results in preclinical proof of concept studies.
For more information on these upcoming opportunities, please contact Hing Kin Chan, Chief Business Officer, at hingkin.chan@dbv-technologies.com.
